Wells Fargo Downgrades NUVL to Hold, Sets $124 Price Target
Wells Fargo lowered its rating on NUVL to hold on June 9, 2026, with a $124 price target, a 0.61% upside from the current price.
Key Points
- Wells Fargo downgraded NUVL to a hold on June 9, 2026, setting a price target of $124.
- Wells Fargo's $124 price target implies 0.61% upside from Nuvalent Inc's ($NUVL) current $123.25 share price.
- NUVL shares are trading at $123.25 amid mixed institutional activity, including a 40% increase by JPMorgan Chase & Co.
- Insider activity includes planned sales by top executives, and multiple analysts have also downgraded the stock.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Wells Fargo recently downgraded NUVL to a hold rating on June 9, 2026, while setting a price target of $124. This move comes as the stock trades at $123.25.
Other Institutional Activity in NUVL
There has been varied activity among major institutional investors in NUVL. Deerfield Management Company maintained its position with 17,248,450 shares valued at about $1.77 billion. FMR LLC reduced its stake by 1,577,925 shares, ending with 9,274,959 shares worth approximately $950.2 million. Meanwhile, Paradigm Biocapital Advisors LP added 55,000 shares to hold 5,324,433 shares valued at around $545.5 million. BlackRock, Inc. slightly increased its holdings by 19,524 shares, now holding 4,824,785 shares worth about $494.3 million. JPMorgan Chase & Co notably increased its position by 883,098 shares, totaling 3,088,349 shares valued at about $298.7 million.
NUVL Stock Snapshot
Shares of NUVL are trading at $123.25. The stock has seen varied institutional interest, indicating a mixed outlook among investors.
$NUVL price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Insider Buying and Selling at Nuvalent Inc
Recent insider activity includes transactions by key executives. On June 9, 2026, Darlene Noci, Chief Development Officer, sold 20,000 shares at an undisclosed price in a planned transaction, while also buying 20,000 shares at $9.59. On June 8, 2026, President and CEO James Richard Porter sold 30,000 shares at a planned price of $88.53, while also purchasing 30,000 shares at $18.93.
Analysts Set New Price Targets
Several analysts have recently updated their ratings and price targets for NUVL. On June 10, 2026, TD Cowen, Barclays, UBS, and Guggenheim all downgraded the stock to a hold, each setting a $124 price target. On June 9, 2026, Wells Fargo, HC Wainwright & Co., Wedbush, and LifeSci Capital also downgraded NUVL to a hold with the same target price of $124.
Bottom Line
The recent downgrade by Wells Fargo and similar moves by other analysts suggest a cautious outlook for NUVL. Institutional activities show mixed confidence, with some funds increasing their stakes while others reduce. Insider sales also highlight potential caution among executives. As with all 13F filings and analyst reports, these reflect past decisions and may not indicate future performance.
Get Nuvalent Inc alerts
New 13F filings, insider trades, and analyst moves on $NUVL, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.